Predictors of Biochemical Response to First-Generation Somatostatin Receptor Ligands in Acromegaly after Surgery: A Real-Life Perspective
Endocrinology Insights · 2025
DOI: 10.1159/000546597 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology Insights, 2025. Verfasst von Inês Meira und 7 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
First-generation somatostatin receptor ligands (fg-SRLs) are currently the first-line medical therapy for persistent or recurrent acromegaly following neurosurgical intervention. Different pretreatment biomarkers might influence the biochemical response to fg-SRL. This study aimed to investigate clinical, biochemical, and radiological predictors of biochemical response to fg-SRL therapy in acromegaly patients previously submitted to neurosurgery.
Methods
This is a retrospective study of a cohort of acromegalic patients who underwent surgery between 2005 and 2023. IGF-1 levels were assessed prior to initiating medical treatment with fg-SRL and again at 6–12 months after fg-SRL therapy. Biochemical response was defined as insulin-like growth factor 1 (IGF-1) ≤1.3 × upper limit of normal. Absolute IGF-1 reduction was also evaluated. Univariate logistic and linear regression analyses were performed.
Results
The study included 48 patients. Univariate analysis revealed that patients who achieved biochemical control had significantly lower baseline IGF-1 levels (p = 0.004) and fasting blood glucose (FBG) values (0.022). A positive association was observed between pretreatment IGF-1 concentration, growth hormone levels after oral glucose tolerance test, FBG at diagnosis, and absolute IGF-1 reduction (β = 0.531, p < 0.001; β = 0.341, p = 0.042; β = 0.522, p < 0.001, respectively). Patients that achieved biochemical response were less likely to present cavernous sinus invasion on imaging (p = 0.002). T2 hyperintense signal was negatively associated with absolute IGF-1 reduction (β = −0.468, p = 0.050).
Conclusion
Lower pretreatment IGF-1 concentration and lower FBG levels were predictive of a biochemical response to fg-SRL. Patients with higher baseline IGF-1 and higher FBG experienced a greater absolute decline in IGF-1, even though they did not reach biochemical control. These findings should be interpreted in the context of the study’s limitations and may contribute to guiding therapeutic decisions.
Zitieren
APA
Meira, I., Ferreira, H. U., Menino, J., Gonçalves, J., Silva, D. F., Belo, S., Pedro, J., & Queirós, J. (2025). Predictors of Biochemical Response to First-Generation Somatostatin Receptor Ligands in Acromegaly after Surgery: A Real-Life Perspective. Endocrinology Insights. https://doi.org/10.1159/000546597
Vancouver
Meira I, Ferreira HU, Menino J, Gonçalves J, Silva DF, Belo S, et al. Predictors of Biochemical Response to First-Generation Somatostatin Receptor Ligands in Acromegaly after Surgery: A Real-Life Perspective. Endocrinology Insights. 2025. doi:10.1159/000546597
BibTeX
@article{Meira2025,
author = {Meira, Inês and Ferreira, Helena Urbano and Menino, João and Gonçalves, Juliana and Silva, Diana Festas and Belo, Sandra and Pedro, Jorge and Queirós, Joana},
title = {Predictors of Biochemical Response to First-Generation Somatostatin Receptor Ligands in Acromegaly after Surgery: A Real-Life Perspective},
journal = {Endocrinology Insights},
year = {2025},
doi = {10.1159/000546597}
}
EUVIMED